These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


154 related items for PubMed ID: 19596413

  • 1. Enhancement of antitumor immune response by targeted interleukin-12 electrogene transfer through antiHER2 single-chain antibody in a murine bladder tumor model.
    Tsai YS, Shiau AL, Chen YF, Tsai HT, Lee HL, Tzai TS, Wu CL.
    Vaccine; 2009 Aug 27; 27(39):5383-92. PubMed ID: 19596413
    [Abstract] [Full Text] [Related]

  • 2. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity.
    Guo J, Wang B, Zhang M, Chen T, Yu Y, Regulier E, Homann HE, Qin Z, Ju DW, Cao X.
    Gene Ther; 2002 Jun 27; 9(12):793-803. PubMed ID: 12040461
    [Abstract] [Full Text] [Related]

  • 3. Coexpression of Flt3 ligand and GM-CSF genes modulates immune responses induced by HER2/neu DNA vaccine.
    Yo YT, Hsu KF, Shieh GS, Lo CW, Chang CC, Wu CL, Shiau AL.
    Cancer Gene Ther; 2007 Nov 27; 14(11):904-17. PubMed ID: 17704754
    [Abstract] [Full Text] [Related]

  • 4. Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12.
    Chen Y, Emtage P, Zhu Q, Foley R, Muller W, Hitt M, Gauldie J, Wan Y.
    Gene Ther; 2001 Feb 27; 8(4):316-23. PubMed ID: 11313806
    [Abstract] [Full Text] [Related]

  • 5. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.
    Wei H, Wang S, Zhang D, Hou S, Qian W, Li B, Guo H, Kou G, He J, Wang H, Guo Y.
    Clin Cancer Res; 2009 Jul 15; 15(14):4612-21. PubMed ID: 19584156
    [Abstract] [Full Text] [Related]

  • 6. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
    Todo T, Martuza RL, Dallman MJ, Rabkin SD.
    Cancer Res; 2001 Jan 01; 61(1):153-61. PubMed ID: 11196154
    [Abstract] [Full Text] [Related]

  • 7. Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.
    Halin C, Gafner V, Villani ME, Borsi L, Berndt A, Kosmehl H, Zardi L, Neri D.
    Cancer Res; 2003 Jun 15; 63(12):3202-10. PubMed ID: 12810649
    [Abstract] [Full Text] [Related]

  • 8. In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity.
    Sun Y, Peng D, Lecanda J, Schmitz V, Barajas M, Qian C, Prieto J.
    Gene Ther; 2000 Sep 15; 7(17):1467-76. PubMed ID: 11001366
    [Abstract] [Full Text] [Related]

  • 9. Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer.
    Yu DS, Lee CF, Hsieh DS, Chang SY.
    Urology; 2004 Mar 15; 63(3):596-601. PubMed ID: 15028475
    [Abstract] [Full Text] [Related]

  • 10. Antitumor and antiangiogenic effects of interleukin 12 gene therapy in murine head and neck carcinoma model.
    Imagawa Y, Satake K, Kato Y, Tahara H, Tsukuda M.
    Auris Nasus Larynx; 2004 Sep 15; 31(3):239-45. PubMed ID: 15364358
    [Abstract] [Full Text] [Related]

  • 11. The essential role of interferon-gamma during interleukin-12 therapy for murine transitional cell carcinoma of the bladder.
    O'Donnell MA, Luo Y, Hunter SE, Chen X, Hayes LL, Clinton SK.
    J Urol; 2004 Mar 15; 171(3):1336-42. PubMed ID: 14767344
    [Abstract] [Full Text] [Related]

  • 12. The antibody-based delivery of interleukin-12 to the tumor neovasculature eradicates murine models of cancer in combination with paclitaxel.
    Pasche N, Wulhfard S, Pretto F, Carugati E, Neri D.
    Clin Cancer Res; 2012 Aug 01; 18(15):4092-103. PubMed ID: 22693354
    [Abstract] [Full Text] [Related]

  • 13. Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity.
    Palmer K, Hitt M, Emtage PC, Gyorffy S, Gauldie J.
    Gene Ther; 2001 Feb 01; 8(4):282-90. PubMed ID: 11313802
    [Abstract] [Full Text] [Related]

  • 14. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW, Li D, McQuone SJ, Ralston R.
    Laryngoscope; 2005 Mar 01; 115(3):391-404. PubMed ID: 15744147
    [Abstract] [Full Text] [Related]

  • 15. B7-1 and interleukin 12 synergistically induce effective antitumor immunity.
    Coughlin CM, Wysocka M, Kurzawa HL, Lee WM, Trinchieri G, Eck SL.
    Cancer Res; 1995 Nov 01; 55(21):4980-7. PubMed ID: 7585539
    [Abstract] [Full Text] [Related]

  • 16. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
    Lee YS, Kim JH, Choi KJ, Choi IK, Kim H, Cho S, Cho BC, Yun CO.
    Clin Cancer Res; 2006 Oct 01; 12(19):5859-68. PubMed ID: 17020994
    [Abstract] [Full Text] [Related]

  • 17. Induction of antitumor immunity with combination of HER2/neu DNA vaccine and interleukin 2 gene-modified tumor vaccine.
    Chen SA, Tsai MH, Wu FT, Hsiang A, Chen YL, Lei HY, Tzai TS, Leung HW, Jin YT, Hsieh CL, Hwang LH, Lai MD.
    Clin Cancer Res; 2000 Nov 01; 6(11):4381-8. PubMed ID: 11106257
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity.
    Ju DW, Yang Y, Tao Q, Song WG, He L, Chen G, Gu S, Ting CC, Cao X.
    Gene Ther; 2000 Oct 01; 7(19):1672-9. PubMed ID: 11083476
    [Abstract] [Full Text] [Related]

  • 19. Eradication of intraperitoneal and distant tumor by adenovirus-mediated interferon-beta gene therapy is attributable to induction of systemic immunity.
    Odaka M, Sterman DH, Wiewrodt R, Zhang Y, Kiefer M, Amin KM, Gao GP, Wilson JM, Barsoum J, Kaiser LR, Albelda SM.
    Cancer Res; 2001 Aug 15; 61(16):6201-12. PubMed ID: 11507073
    [Abstract] [Full Text] [Related]

  • 20. Insights into the mechanism of anti-tumor immunity in mice vaccinated with the human HER2/neu extracellular domain plus anti-HER2/neu IgG3-(IL-2) or anti-HER2/neu IgG3-(GM-CSF) fusion protein.
    Dela Cruz JS, Morrison SL, Penichet ML.
    Vaccine; 2005 Sep 15; 23(39):4793-803. PubMed ID: 15967544
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.